nivolumab
ono Pharmaceuticals,BMS
['renal,(-adrenal)']
you can use this list of recommendations shared by dr. eric jonasch board director at ikcc to follow up renal cell carcinoma trial results from esmo 2022 last week via 
IKCC is a Registered Foundation providing a global voice for national & regional patient support and advocacy organisations focused on kidney cancers.